RECURRENT MYCOSIS FUNGOIDES
Clinical trials for RECURRENT MYCOSIS FUNGOIDES explained in plain language.
Never miss a new study
Get alerted when new RECURRENT MYCOSIS FUNGOIDES trials appear
Sign up with your email to follow new studies for RECURRENT MYCOSIS FUNGOIDES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Scientists unleash engineered virus to hunt down blood cancers
Disease control Recruiting nowThis early-stage trial is testing a new treatment for patients whose blood cancers have returned or not responded to standard therapies. The treatment uses a modified virus that is designed to selectively infect and kill cancer cells while sparing healthy ones. Researchers are st…
Matched conditions: RECURRENT MYCOSIS FUNGOIDES
Phase: PHASE1 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
When a rash might be a good sign: study probes skin lymphoma drug side effect
Knowledge-focused Recruiting nowThis study aims to better understand a common rash that occurs in patients with two types of skin lymphoma (mycosis fungoides and Sézary syndrome) who are taking the drug mogamulizumab. Researchers will observe 100 patients to learn how often this rash happens and to find ways to…
Matched conditions: RECURRENT MYCOSIS FUNGOIDES
Sponsor: City of Hope Medical Center • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:34 UTC